Strs Ohio Biocryst Pharmaceuticals Inc Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$10.79 - $14.81 $16,184 - $22,215	1,500 New	1,500 $18,000
Q2 2022 Jul 25, 2022	SELL	$7.89 - $17.88 $15,780 - $35,760	-2,000 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$11.56 - $19.76 $23,120 - $39,520	2,000 New	2,000 $32,000
Q4 2021 Jan 24, 2022	SELL	$11.18 - $15.46 $38,012 - $52,564	-3,400 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$14.21 - $17.65 $48,314 - $60,009	3,400 New	3,400 $48,000
Q3 2020 Dec 14, 2020	SELL	$3.43 - $5.53 $56,252 - $90,692	-16,400 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$1.9 - $5.61 $31,160 - $92,004	16,400 New	16,400 $78,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.